Skip to main content
. 2019 May 13;11(5):661. doi: 10.3390/cancers11050661
YC-1 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole
TCF4 T cell-specific factor 4
EBP1 ErbB3 binding protein 1
HCC hepatocellular carcinoma
STF Super-TOPflash
LOPAC Library of Pharmacologically Active Compounds
co-IP co-immunoprecipitation
HIF-1α hypoxia-inducible factor 1-α
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium